DCF — CARIBBEAN MEDICAL CENTER
Enterprise Value: $-6.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-6.8M
Enterprise Value
$-2.8M
PV of Cash Flows
$-3.9M
PV of Terminal Value
$-6.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $25.6M | $-0.0M | -0.0% | $-1.1M | $-1.0M |
| Year 2 | $26.4M | $0.2M | 1.0% | $-0.9M | $-0.7M |
| Year 3 | $27.1M | $0.5M | 2.0% | $-0.6M | $-0.5M |
| Year 4 | $28.0M | $0.7M | 2.0% | $-0.5M | $-0.3M |
| Year 5 | $28.8M | $0.8M | 3.0% | $-0.5M | $-0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-6.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$24.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.005920333990146157
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5